世界の医薬品資産管理市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pharmaceutical Asset Managements Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4556
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、医薬品資産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア（製薬資産）、ソフトウェア（製薬資産））、用途別市場規模（医薬品偽造防止、サプライチェーン管理、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・医薬品資産管理の市場動向
・企業の競争状況、市場シェア
・医薬品資産管理の種類別市場規模（ハードウェア（製薬資産）、ソフトウェア（製薬資産））
・医薬品資産管理の用途別市場規模（医薬品偽造防止、サプライチェーン管理、その他）
・医薬品資産管理の北米市場規模2016-2027（アメリカ、カナダ）
・医薬品資産管理のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・医薬品資産管理のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・医薬品資産管理の中南米市場規模2016-2027（メキシコ、ブラジル）
・医薬品資産管理の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（McKesson Corporation、Cerner Corporation、Siemens Healthcare、GE Healthcare、Allscripts、Epic System、IBM Corporation）
・結論

Market Analysis and Insights: Global Pharmaceutical Asset Managements Market
The global Pharmaceutical Asset Managements market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Asset Managements market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Asset Managements market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Asset Managements market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Asset Managements market.

Global Pharmaceutical Asset Managements Scope and Market Size
Pharmaceutical Asset Managements market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Asset Managements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hardware (Pharma Asset)
Software (Pharma Asset)

Segment by Application
Anti-drug Counterfeiting
Supply Chain Management
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
McKesson Corporation
Cerner Corporation
Siemens Healthcare
GE Healthcare
Allscripts
Epic System
IBM Corporation

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Asset Managements Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hardware (Pharma Asset)
1.2.3 Software (Pharma Asset)
1.3 Market by Application
1.3.1 Global Pharmaceutical Asset Managements Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anti-drug Counterfeiting
1.3.3 Supply Chain Management
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pharmaceutical Asset Managements Market Perspective (2016-2027)
2.2 Pharmaceutical Asset Managements Growth Trends by Regions
2.2.1 Pharmaceutical Asset Managements Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical Asset Managements Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical Asset Managements Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical Asset Managements Industry Dynamic
2.3.1 Pharmaceutical Asset Managements Market Trends
2.3.2 Pharmaceutical Asset Managements Market Drivers
2.3.3 Pharmaceutical Asset Managements Market Challenges
2.3.4 Pharmaceutical Asset Managements Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Asset Managements Players by Revenue
3.1.1 Global Top Pharmaceutical Asset Managements Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical Asset Managements Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical Asset Managements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Asset Managements Revenue
3.4 Global Pharmaceutical Asset Managements Market Concentration Ratio
3.4.1 Global Pharmaceutical Asset Managements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Asset Managements Revenue in 2020
3.5 Pharmaceutical Asset Managements Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Asset Managements Product Solution and Service
3.7 Date of Enter into Pharmaceutical Asset Managements Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Asset Managements Breakdown Data by Type
4.1 Global Pharmaceutical Asset Managements Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical Asset Managements Forecasted Market Size by Type (2022-2027)

5 Pharmaceutical Asset Managements Breakdown Data by Application
5.1 Global Pharmaceutical Asset Managements Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical Asset Managements Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pharmaceutical Asset Managements Market Size (2016-2027)
6.2 North America Pharmaceutical Asset Managements Market Size by Type
6.2.1 North America Pharmaceutical Asset Managements Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical Asset Managements Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical Asset Managements Market Size by Type (2016-2027)
6.3 North America Pharmaceutical Asset Managements Market Size by Application
6.3.1 North America Pharmaceutical Asset Managements Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical Asset Managements Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical Asset Managements Market Size by Application (2016-2027)
6.4 North America Pharmaceutical Asset Managements Market Size by Country
6.4.1 North America Pharmaceutical Asset Managements Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical Asset Managements Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pharmaceutical Asset Managements Market Size (2016-2027)
7.2 Europe Pharmaceutical Asset Managements Market Size by Type
7.2.1 Europe Pharmaceutical Asset Managements Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical Asset Managements Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical Asset Managements Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical Asset Managements Market Size by Application
7.3.1 Europe Pharmaceutical Asset Managements Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical Asset Managements Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical Asset Managements Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical Asset Managements Market Size by Country
7.4.1 Europe Pharmaceutical Asset Managements Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical Asset Managements Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Asset Managements Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical Asset Managements Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical Asset Managements Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical Asset Managements Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical Asset Managements Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical Asset Managements Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical Asset Managements Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical Asset Managements Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical Asset Managements Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical Asset Managements Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical Asset Managements Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical Asset Managements Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pharmaceutical Asset Managements Market Size (2016-2027)
9.2 Latin America Pharmaceutical Asset Managements Market Size by Type
9.2.1 Latin America Pharmaceutical Asset Managements Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical Asset Managements Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical Asset Managements Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical Asset Managements Market Size by Application
9.3.1 Latin America Pharmaceutical Asset Managements Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical Asset Managements Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical Asset Managements Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical Asset Managements Market Size by Country
9.4.1 Latin America Pharmaceutical Asset Managements Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical Asset Managements Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Asset Managements Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical Asset Managements Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical Asset Managements Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical Asset Managements Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical Asset Managements Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical Asset Managements Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical Asset Managements Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical Asset Managements Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical Asset Managements Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical Asset Managements Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical Asset Managements Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical Asset Managements Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 McKesson Corporation
11.1.1 McKesson Corporation Company Details
11.1.2 McKesson Corporation Business Overview
11.1.3 McKesson Corporation Pharmaceutical Asset Managements Introduction
11.1.4 McKesson Corporation Revenue in Pharmaceutical Asset Managements Business (2016-2021)
11.1.5 McKesson Corporation Recent Development
11.2 Cerner Corporation
11.2.1 Cerner Corporation Company Details
11.2.2 Cerner Corporation Business Overview
11.2.3 Cerner Corporation Pharmaceutical Asset Managements Introduction
11.2.4 Cerner Corporation Revenue in Pharmaceutical Asset Managements Business (2016-2021)
11.2.5 Cerner Corporation Recent Development
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Details
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Pharmaceutical Asset Managements Introduction
11.3.4 Siemens Healthcare Revenue in Pharmaceutical Asset Managements Business (2016-2021)
11.3.5 Siemens Healthcare Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Pharmaceutical Asset Managements Introduction
11.4.4 GE Healthcare Revenue in Pharmaceutical Asset Managements Business (2016-2021)
11.4.5 GE Healthcare Recent Development
11.5 Allscripts
11.5.1 Allscripts Company Details
11.5.2 Allscripts Business Overview
11.5.3 Allscripts Pharmaceutical Asset Managements Introduction
11.5.4 Allscripts Revenue in Pharmaceutical Asset Managements Business (2016-2021)
11.5.5 Allscripts Recent Development
11.6 Epic System
11.6.1 Epic System Company Details
11.6.2 Epic System Business Overview
11.6.3 Epic System Pharmaceutical Asset Managements Introduction
11.6.4 Epic System Revenue in Pharmaceutical Asset Managements Business (2016-2021)
11.6.5 Epic System Recent Development
11.7 IBM Corporation
11.7.1 IBM Corporation Company Details
11.7.2 IBM Corporation Business Overview
11.7.3 IBM Corporation Pharmaceutical Asset Managements Introduction
11.7.4 IBM Corporation Revenue in Pharmaceutical Asset Managements Business (2016-2021)
11.7.5 IBM Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pharmaceutical Asset Managements Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hardware (Pharma Asset)
Table 3. Key Players of Software (Pharma Asset)
Table 4. Global Pharmaceutical Asset Managements Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pharmaceutical Asset Managements Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmaceutical Asset Managements Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pharmaceutical Asset Managements Market Share by Regions (2016-2021)
Table 8. Global Pharmaceutical Asset Managements Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pharmaceutical Asset Managements Market Share by Regions (2022-2027)
Table 10. Pharmaceutical Asset Managements Market Trends
Table 11. Pharmaceutical Asset Managements Market Drivers
Table 12. Pharmaceutical Asset Managements Market Challenges
Table 13. Pharmaceutical Asset Managements Market Restraints
Table 14. Global Pharmaceutical Asset Managements Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pharmaceutical Asset Managements Market Share by Players (2016-2021)
Table 16. Global Top Pharmaceutical Asset Managements Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Asset Managements as of 2020)
Table 17. Ranking of Global Top Pharmaceutical Asset Managements Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pharmaceutical Asset Managements Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmaceutical Asset Managements Product Solution and Service
Table 21. Date of Enter into Pharmaceutical Asset Managements Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmaceutical Asset Managements Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pharmaceutical Asset Managements Revenue Market Share by Type (2016-2021)
Table 25. Global Pharmaceutical Asset Managements Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pharmaceutical Asset Managements Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pharmaceutical Asset Managements Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pharmaceutical Asset Managements Revenue Market Share by Application (2016-2021)
Table 29. Global Pharmaceutical Asset Managements Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pharmaceutical Asset Managements Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pharmaceutical Asset Managements Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pharmaceutical Asset Managements Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pharmaceutical Asset Managements Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pharmaceutical Asset Managements Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pharmaceutical Asset Managements Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pharmaceutical Asset Managements Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pharmaceutical Asset Managements Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pharmaceutical Asset Managements Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pharmaceutical Asset Managements Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pharmaceutical Asset Managements Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pharmaceutical Asset Managements Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pharmaceutical Asset Managements Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pharmaceutical Asset Managements Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pharmaceutical Asset Managements Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharmaceutical Asset Managements Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Asset Managements Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharmaceutical Asset Managements Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutical Asset Managements Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pharmaceutical Asset Managements Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pharmaceutical Asset Managements Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pharmaceutical Asset Managements Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pharmaceutical Asset Managements Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pharmaceutical Asset Managements Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pharmaceutical Asset Managements Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pharmaceutical Asset Managements Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pharmaceutical Asset Managements Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharmaceutical Asset Managements Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharmaceutical Asset Managements Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharmaceutical Asset Managements Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pharmaceutical Asset Managements Market Size by Country (2022-2027) & (US$ Million)
Table 61. McKesson Corporation Company Details
Table 62. McKesson Corporation Business Overview
Table 63. McKesson Corporation Pharmaceutical Asset Managements Product
Table 64. McKesson Corporation Revenue in Pharmaceutical Asset Managements Business (2016-2021) & (US$ Million)
Table 65. McKesson Corporation Recent Development
Table 66. Cerner Corporation Company Details
Table 67. Cerner Corporation Business Overview
Table 68. Cerner Corporation Pharmaceutical Asset Managements Product
Table 69. Cerner Corporation Revenue in Pharmaceutical Asset Managements Business (2016-2021) & (US$ Million)
Table 70. Cerner Corporation Recent Development
Table 71. Siemens Healthcare Company Details
Table 72. Siemens Healthcare Business Overview
Table 73. Siemens Healthcare Pharmaceutical Asset Managements Product
Table 74. Siemens Healthcare Revenue in Pharmaceutical Asset Managements Business (2016-2021) & (US$ Million)
Table 75. Siemens Healthcare Recent Development
Table 76. GE Healthcare Company Details
Table 77. GE Healthcare Business Overview
Table 78. GE Healthcare Pharmaceutical Asset Managements Product
Table 79. GE Healthcare Revenue in Pharmaceutical Asset Managements Business (2016-2021) & (US$ Million)
Table 80. GE Healthcare Recent Development
Table 81. Allscripts Company Details
Table 82. Allscripts Business Overview
Table 83. Allscripts Pharmaceutical Asset Managements Product
Table 84. Allscripts Revenue in Pharmaceutical Asset Managements Business (2016-2021) & (US$ Million)
Table 85. Allscripts Recent Development
Table 86. Epic System Company Details
Table 87. Epic System Business Overview
Table 88. Epic System Pharmaceutical Asset Managements Product
Table 89. Epic System Revenue in Pharmaceutical Asset Managements Business (2016-2021) & (US$ Million)
Table 90. Epic System Recent Development
Table 91. IBM Corporation Company Details
Table 92. IBM Corporation Business Overview
Table 93. IBM Corporation Pharmaceutical Asset Managements Product
Table 94. IBM Corporation Revenue in Pharmaceutical Asset Managements Business (2016-2021) & (US$ Million)
Table 95. IBM Corporation Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Asset Managements Market Share by Type: 2020 VS 2027
Figure 2. Hardware (Pharma Asset) Features
Figure 3. Software (Pharma Asset) Features
Figure 4. Global Pharmaceutical Asset Managements Market Share by Application: 2020 VS 2027
Figure 5. Anti-drug Counterfeiting Case Studies
Figure 6. Supply Chain Management Case Studies
Figure 7. Other Case Studies
Figure 8. Pharmaceutical Asset Managements Report Years Considered
Figure 9. Global Pharmaceutical Asset Managements Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pharmaceutical Asset Managements Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pharmaceutical Asset Managements Market Share by Regions: 2020 VS 2027
Figure 12. Global Pharmaceutical Asset Managements Market Share by Regions (2022-2027)
Figure 13. Global Pharmaceutical Asset Managements Market Share by Players in 2020
Figure 14. Global Top Pharmaceutical Asset Managements Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Asset Managements as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pharmaceutical Asset Managements Revenue in 2020
Figure 16. Global Pharmaceutical Asset Managements Revenue Market Share by Type (2016-2021)
Figure 17. Global Pharmaceutical Asset Managements Revenue Market Share by Type (2022-2027)
Figure 18. North America Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pharmaceutical Asset Managements Market Share by Type (2016-2027)
Figure 20. North America Pharmaceutical Asset Managements Market Share by Application (2016-2027)
Figure 21. North America Pharmaceutical Asset Managements Market Share by Country (2016-2027)
Figure 22. United States Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pharmaceutical Asset Managements Market Share by Type (2016-2027)
Figure 26. Europe Pharmaceutical Asset Managements Market Share by Application (2016-2027)
Figure 27. Europe Pharmaceutical Asset Managements Market Share by Country (2016-2027)
Figure 28. Germany Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pharmaceutical Asset Managements Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pharmaceutical Asset Managements Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pharmaceutical Asset Managements Market Share by Region (2016-2027)
Figure 38. China Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pharmaceutical Asset Managements Market Share by Type (2016-2027)
Figure 46. Latin America Pharmaceutical Asset Managements Market Share by Application (2016-2027)
Figure 47. Latin America Pharmaceutical Asset Managements Market Share by Country (2016-2027)
Figure 48. Mexico Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pharmaceutical Asset Managements Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pharmaceutical Asset Managements Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pharmaceutical Asset Managements Market Share by Country (2016-2027)
Figure 54. Turkey Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pharmaceutical Asset Managements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. McKesson Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2016-2021)
Figure 58. Cerner Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2016-2021)
Figure 59. Siemens Healthcare Revenue Growth Rate in Pharmaceutical Asset Managements Business (2016-2021)
Figure 60. GE Healthcare Revenue Growth Rate in Pharmaceutical Asset Managements Business (2016-2021)
Figure 61. Allscripts Revenue Growth Rate in Pharmaceutical Asset Managements Business (2016-2021)
Figure 62. Epic System Revenue Growth Rate in Pharmaceutical Asset Managements Business (2016-2021)
Figure 63. IBM Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の医薬品資産管理市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Asset Management Market Size, Status and Forecast 2021-2027
QYR2104Z4555 2021年4月 93Pages
QYResearch社発行の本調査資料では、医薬品資産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア（製薬資産）、ソフトウェア（製薬資産））、用途別市場規模（医薬品偽造防止、サプライチェーン管理）、主要地域別市場規模（北米、ア...

世界の医療資産管理市場規模・現状・予測（2021年-2027年）

Global Healthcare Asset Management Market Size, Status and Forecast 2021-2027
QYR2104Z2704 2021年4月 97Pages
QYResearch社発行の本調査資料では、医療資産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RFID、RTLS、超音波、赤外線）、用途別市場規模（病院、製薬）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国...

世界のグリッド資産管理市場規模・現状・予測（2021年-2027年）

Global Grid Asset Management Market Size, Status and Forecast 2021-2027
QYR2104Z2636 2021年4月 90Pages
QYResearch社発行の本調査資料では、グリッド資産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クラシックグリッド資産管理、スマートグリッド資産管理）、用途別市場規模（家庭用グリッド資産、商業用グリッド資産、産業用グリッド資産）、主...

世界のワイヤレス医療資産管理市場規模・現状・予測（2021年-2027年）

Global Wireless Healthcare Asset Management Market Size, Status and Forecast 2021-2027
QYR2104Z6047 2021年4月 92Pages
QYResearch社発行の本調査資料では、ワイヤレス医療資産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アセットタグ、センサー、ソフトウェア、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の病院向けアセットマネジメント市場規模・現状・予測（2021年-2027年）

Global Hospital Asset Management Market Size, Status and Forecast 2021-2027
QYR2104Z2908 2021年4月 97Pages
QYResearch社発行の本調査資料では、病院向けアセットマネジメントのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リアルタイムロケーションシステム（RTLS）、無線周波数識別（RFID）、超音波、赤外線）、用途別市場規模（患者管理、スタッ...

世界の病院向けアセットマネジメント市場規模・現状・予測（2021年-2027年）

世界の製品ライフサイクル・アセットマネジメントにおけるIoT（モノのインターネット）市場規模・現状・予測（2021年-2027年）

Global IoT in Product Lifecycle and Asset Management Market Size, Status and Forecast 2021-2027
QYR2104Z3262 2021年4月 95Pages
QYResearch社発行の本調査資料では、製品ライフサイクル・アセットマネジメントにおけるIoT（モノのインターネット）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア、ソフトウェア、サービス）、用途別市場規模（航空宇宙・防衛、製...

世界のデジタル資産取引市場規模・現状・予測（2021年-2027年）

Global Digital Asset Transaction Market Size, Status and Forecast 2021-2027
QYR2104Z1864 2021年4月 93Pages
QYResearch社発行の本調査資料では、デジタル資産取引のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（公開鍵ハッシュ（P2PKH）、公開鍵（P2PK）、スクリプトハッシュ（P2SH））、用途別市場規模（Eコマース、小売、投資）、主要地域別...

世界のデジタル資産取引市場規模・現状・予測（2021年-2027年）

世界のデジタル資産取引システム開発市場規模・現状・予測（2021年-2027年）

Global Digital Asset Trading System Development Market Size, Status and Forecast 2021-2027
QYR2104Z1863 2021年4月 98Pages
QYResearch社発行の本調査資料では、デジタル資産取引システム開発のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（製品開発、テクニカルサポート、コンサルティング）、用途別市場規模（ビットコイン取引、ライトコイン取引、その他）、主要地域別市...

世界の医薬品資産管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pharmaceutical Asset Management Market The global Pharmaceutical Asset Management market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
世界の製品ライフサイクル・アセットマネジメントにおけるIoT（モノのインターネット）市場規模・現状・予測（2021年-2027年） The Internet of Things (IoT) is the network of physical devices, vehicles, home appliances, and other items embedded with electronics, software, sensors, actuators, and connectivity which enables these things to connect and exchange data, creating opportunities for more direct integration of the phy…
世界の医療資産管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Healthcare Asset Management Market The global Healthcare Asset Management market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
世界のグリッド資産管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Grid Asset Management Market The global Grid Asset Management market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
世界のワイヤレス医療資産管理市場規模・現状・予測（2021年-2027年） The use of wireless systems in healthcare applications has been greatly enhanced. Medical institutions are increasingly using wireless technology to enhance asset management and thus improve operational efficiency. Hospitals can avoid financial losses associated with the loss or damage of expensive …